Localized cancer of the prostate: Survival and loss of life expectancy;Lokaliseret cancer prostatae: Overlevelse og tab af leveår

Ugeskrift for Laeger

Volumn 160, Issue 31, 1998, Pages 4517-4520

  Brasso, Klaus ^a   Friis, Søren ^a   Juel, Knud ^a   Jørgensen, Torben ^a   Iversen, Peter ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DENMARK; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSTATE TUMOR; REGISTER; SURVIVAL RATE;

AGED; DENMARK; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; REGISTRIES; SURVIVAL RATE;

EID: 0032572441     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Storm HH, Michelsen E, Nielsen AL. Cancer incidence in Denmark 1993. Copenhagen: Danish Cancer Society, 1996.
2. Brasso K, Friis S, Kjær SK, Iversen P. Cancer prostatae hos mænd under 65 år, forekomst og behov for udredning. Ugeskr Læger 1997; 159. 2543-5.
3. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG Jr, Wennberg JE. A structured literature review of treatment for localized prostate cancer. Arch Fam Med 1993; 2: 487-93
4. Flemming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993; 269: 2650-8
5. Carstensen B. Survival of Danish cancer patients. Material and methods APMIS 1993; 101 (suppl 3): 3-8.
6. Andersen PK, Væth M. Statistisk analyse af overlevelsesdata ved Iægevidenskabelige undersøgelser. København: FADL's forlag, 1993.
7. Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chron Dis 1977; 30: 585-97.
8. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242-8
9. Grönberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Ångström T. Prostate cancer in Northern Sweden. Acta Oncol 1994, 33: 359-63.
10. Grönberg H, Damber JE, Jonsson H, Lenner P. Patient age as a prognostic factor in prostate cancer. J Urol 1994; 152: 892-5.
11. Dillioglugil Ö, Miles BJ, Scardino PT. Current controversies in the management of localized prostate cancer. Eur Urol 1995; 28: 85-101.
12. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 1996; 156: 137-143.
13. Adolfsson J, Carstensen J, Löwhagen T Deferred treatment in clinically localised prostatic carcinoma. Br J Urol 1992; 69: 183-7.
14. Adolfsson J, Steineck G, Whitmore WF Jr Recent results of management of palpable clinically localized prostate cancer. Cancer 1993; 72: 310-22.
15. Dugan JA, Bostwick DG, Myers RP, Quin J, Bergstralh EJ, Oesterling JE. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 1996; 275: 288-94.
16. Adolfsson J, Carstensen J. Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. J Urol 1991; 146: 96-8.
17. Labric F, Cusan L, Gomcz JL, Diamond P, Candas B. Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality. J Clin Endocrinol Metab 1995; 80: 2002-13.
18. Tretli S, Engeland A, Haldorsen T, Hakulinen T, Hörte LG, Luostarinen T et al. Prostate cancer - look to Denmark? J Natl Cancer Inst 1996; 88: 28
19. Jonsson PM, Danneskiold-Samsøe B, Heggestad T, Iversen P, Leisti S Management of early prostatic cancer in the Nordic Countries: variations in clinical policies and physicians' attitudes toward radical treatment. Int J Technol Assess in Health Care 1995; 11: 66-78.
20. Iversen P. Prostatacancer. Ugeskr Læger 1997; 159: 2519.